OptiNose (OPTN)
(Delayed Data from NSDQ)
$0.86 USD
-0.03 (-2.95%)
Updated Sep 17, 2024 03:59 PM ET
After-Market: $0.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Income Statements
Fiscal Year end for OptiNose, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 71 | 76 | 75 | 49 | 35 |
Cost Of Goods | 9 | 9 | 9 | 8 | 5 |
Gross Profit | 62 | 67 | 66 | 42 | 29 |
Selling & Adminstrative & Depr. & Amort Expenses | 85 | 123 | 132 | 129 | 125 |
Income After Depreciation & Amortization | -23 | -56 | -66 | -87 | -96 |
Non-Operating Income | 7 | -2 | 0 | 0 | -5 |
Interest Expense | 20 | 17 | 16 | 13 | 10 |
Pretax Income | -35 | -75 | -82 | -100 | -110 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -35 | -75 | -82 | -100 | -110 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -35 | -75 | -82 | -100 | -110 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -21 | -53 | -64 | -85 | -94 |
Depreciation & Amortization (Cash Flow) | 2 | 3 | 2 | 3 | 2 |
Income After Depreciation & Amortization | -23 | -56 | -66 | -87 | -96 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 112.08 | 85.90 | 56.85 | 48.28 | 41.88 |
Diluted EPS Before Non-Recurring Items | -0.32 | -0.87 | -1.45 | -2.07 | -2.63 |
Diluted Net EPS (GAAP) | -0.32 | -0.87 | -1.45 | -2.07 | -2.63 |
Fiscal Year end for OptiNose, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 20.49 | 14.88 | 19.86 | 19.82 | 19.45 |
Cost Of Goods | 1.98 | 1.23 | 2.13 | 2.23 | 2.57 |
Gross Profit | 18.51 | 13.65 | 17.73 | 17.60 | 16.88 |
SG&A, R&D, and Dept/Amort Expenses | 25.06 | 21.73 | 20.25 | 19.29 | 21.05 |
Income After SG&A, R&D, and Dept/Amort Expenses | -6.55 | -8.08 | -2.52 | -1.69 | -4.17 |
Non-Operating Income | 3.91 | -1.02 | -2.37 | -2.66 | 11.63 |
Interest Expense | 4.95 | 4.97 | 5.09 | 4.94 | 4.82 |
Pretax Income | -7.58 | -14.07 | -9.97 | -9.29 | 2.63 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.58 | -14.07 | -9.97 | -9.29 | 2.63 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.58 | -14.07 | -9.97 | -9.29 | 2.63 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 150.70 | 112.60 | 112.31 | 112.23 | 112.04 |
Diluted EPS Before Non-Recurring Items | -0.07 | -0.12 | -0.09 | -0.08 | 0.02 |
Diluted Net EPS (GAAP) | -0.07 | -0.12 | -0.09 | -0.08 | 0.02 |